VVM

Versant Venture Management Portfolio holdings

AUM $82.1M
This Quarter Return
+12.62%
1 Year Return
-26.22%
3 Year Return
+73.87%
5 Year Return
-1.11%
10 Year Return
+1,578.11%
AUM
$131M
AUM Growth
+$131M
Cap. Flow
+$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
8
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

1 Healthcare 66.03%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
BOLD
1
DELISTED
Audentes Therapeutics, Inc
BOLD
$50.9M 38.71% 1,806,832
IMDZ
2
DELISTED
Immune Design Corp.
IMDZ
$23.2M 17.69% 2,208,210
AKAO
3
DELISTED
Achaogen, Inc.
AKAO
$20.6M 15.68% 1,281,152
OCUL icon
4
Ocular Therapeutix
OCUL
$2.12B
$13.8M 10.54% 2,215,384
CLVS
5
DELISTED
Clovis Oncology, Inc.
CLVS
$8.38M 6.38% 101,855
CBAY
6
DELISTED
Cymabay Therapeutics
CBAY
$8.26M 6.29% 1,048,601
VANI icon
7
Vivani Medical
VANI
$68.1M
$5.39M 4.1% 4,492,975
OPGN
8
DELISTED
OpGen, Inc
OPGN
$791K 0.6% 2,554,211